SCHEMBL6714040

SCHEMBL6714040

CCSc1ccc(C(=O)Nc2cccc3cc(C(=O)Nc4ccc(Cl)cc4-c4nnn[nH]4)[nH]c23)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F10 P00742 1/20 0.38
PLCG2 P16885 1/20 0.37
STK33 Q9BYT3 1/20 0.36
TP53 P04637 3/20 0.36
MAPT P10636 2/20 0.36
POLB P06746 2/20 0.36
LMNA P02545 2/20 0.36
PTK2B Q14289 1/20 0.36
NHERF1 O14745 3/20 0.36
MAPK1 P28482 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
GAA P10253 2/20 0.35
KDR P35968 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
TRPV1 Q8NER1 1/20 0.35
KCNK2 O95069 1/20 0.35
KCNK10 P57789 1/20 0.35
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
HPGD P15428 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6711714 0.91 GPR35 (0.39) TP53MAPTPOLBLMNAMAPK1
SCHEMBL6711787 0.89 SIRT2 (0.40) TP53MAPTPOLBLMNAMAPK1
SCHEMBL6713754 0.89 SERPINE1 (0.43) PLCG2STK33NHERF1GAAKDR
SCHEMBL6710087 0.88 PLCG2 (0.39) F10PLCG2STK33TP53MAPT
SCHEMBL6708019 0.87 GPR35 (0.44) PLCG2STK33MAPTPTK2BNHERF1
SCHEMBL6710112 0.87 MAP3K5 (0.45) F10PLCG2STK33TP53MAPT
SCHEMBL6707724 0.87 L3MBTL1 (0.41) PLCG2TP53MAPTPOLBLMNA
SCHEMBL6710315 0.87 POLB (0.39) PLCG2TP53MAPTPOLBLMNA
SCHEMBL6710125 0.86 SERPINE1 (0.48) F10PLCG2STK33MAPTLMNA
SCHEMBL6710128 0.86 CYSLTR2 (0.42) TP53MAPTPOLBLMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed
WO-2004018461-A2 ANTIBACTERIAL BENZOIC ACID DERIVATIVES PHARMACIA & UPJOHN COMPANY LLC (US) 2004-03-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 F10 2246/4885PLCG2 4289/4885STK33 3606/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.